Carlsmed, Inc. (NASDAQ: CARL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CARLSMED, INC.

Carlsmed, Inc. (NASDAQ: CARL)
Listen to this Section


$11.08
-0.0650 ( -0.58% ) 50.0K

Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient's unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Market Data


Open $11.08
Previous Close $11.14
Volume 50.0K
Market Cap $302.84M
Day Range $11.01 - $11.29
52 Week Range $8.50 - $17.19
Shares Outstanding 27.18M
Change % -0.58%
Net Change ▼ -0.0650
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
IPO Year2025
CountryUnited States
UnderwriterBofA Securities, Goldman Sachs, Piper Sandler, Truist Securities, BTIG, more

Insider Ownership Transactions

Total Amount Purchased: 11,093,517.00

Date Type Amount Purchased Purchaser
2025-07-24 Buy 17333.00 YOUNG PHILIP M
2025-07-24 Buy 17333.00 ROOT JONATHAN D
2025-07-24 Buy 3680506.00 Mittendorff Robert II
2025-07-24 Buy 17333.00 Sidow Kevin
2025-07-24 Buy 3680506.00 B CAPITAL GROUP MANAGEMENT, L.P.
2025-07-24 Buy 3680506.00 B CAPITAL GROUP MANAGEMENT, L.P.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 24, 2025
4 Insider transactions 1 Jul 24, 2025
4 Insider transactions 1 Jul 24, 2025
4 Insider transactions 1 Jul 24, 2025
8-k 8K-related 12 Jul 24, 2025
4 Insider transactions 1 Jul 24, 2025
4 Insider transactions 1 Jul 24, 2025
3 Insider transactions 1 Jul 22, 2025
3 Insider transactions 2 Jul 22, 2025
3 Insider transactions 2 Jul 22, 2025

Latest News


× Before browsing our site, please accept our cookies policy